atorvastatin has been researched along with 1-anilino-8-naphthalenesulfonate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connelly, PW; Hegele, RA; Little, JA | 1 |
| Desager, JP; Descamps, O; Heller, F; Hondekijn, JC | 1 |
| Dosch, R; Farber, SA; Halpern, ME; Hendrickson, EK; Hendrickson, HS; Ho, SY; Johnson, ID; Mullins, MC; Pack, M; Wagner, DS | 1 |
| Funatsu, T; Goto, M; Ida, M; Kakuta, H; Miyata, K; Nishijima, S; Suzuki, M; Tanaka, H; Yasuda, S | 1 |
| Berk-Planken, II; Bootsma, AH; Hoogerbrugge, N; Jansen, H; Stolk, RP | 1 |
| Botma, GJ; Jansen, H; van Deursen, D; van Hoek, M; Verhoeven, AJ; Vieira, D | 1 |
| Arístegui, R; Artieda, M; Cenarro, A; Civeira, F; Díaz, C; Gañán, A; Gonzalvo, C; Meriño-Ibarra, E; Pocoví, M; Sol, JM | 1 |
| Briand, F; Krempf, M; Magot, T; Nguyen, P; Ouguerram, K | 1 |
| Hill, JS; Qiu, G | 1 |
| Aicart Ramos, M; Albillos Martínez, A; Cuño Roldán, JL; Moreira Vicente, V; Rodríguez de Santiago, E; Téllez Villajos, L | 1 |
2 trial(s) available for atorvastatin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant.
Topics: Aged; Alleles; Atorvastatin; Black People; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Genetic Variation; Heptanoic Acids; Heterozygote; Humans; Hyperlipidemias; Lipase; Liver; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Pyrroles; Sex Characteristics; White People | 2003 |
Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Topics: Adult; Aged; Atorvastatin; Bezafibrate; Cytosine; Female; Genetic Variation; Genotype; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Lipoproteins; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrroles; Reference Values; Thymine | 2005 |
8 other study(ies) available for atorvastatin and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Atorvastatin in the management of an index patient with complete hepatic lipase deficiency.
Topics: Anticholesteremic Agents; Atorvastatin; Follow-Up Studies; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipase; Lipids; Liver; Male; Pyrroles | 1999 |
Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity?
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hyperlipidemias; Lipase; Lipoproteins, LDL; Liver; Male; Middle Aged; Pyrroles | 1999 |
Genetic analysis of digestive physiology using fluorescent phospholipid reporters.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bile Acids and Salts; Boron Compounds; Cholesterol; Digestive System; Digestive System Physiological Phenomena; Fluorescent Dyes; Gallbladder; Heptanoic Acids; Larva; Lipase; Mice; Microscopy, Fluorescence; Microscopy, Video; Mutation; Phospholipids; Pyrroles; Signal Transduction; Zebrafish | 2001 |
Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Coenzyme A Ligases; Dietary Sucrose; Disease Models, Animal; Down-Regulation; Fatty Acids, Nonesterified; Heptanoic Acids; Hypertriglyceridemia; Lipase; Lipoproteins, VLDL; Liver; Male; Oleic Acid; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triglycerides; Tritium | 2002 |
Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.
Topics: Anticholesteremic Agents; Atorvastatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; DNA-Binding Proteins; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Homeostasis; Humans; Lipase; Liver Neoplasms; Oleic Acid; Promoter Regions, Genetic; Pyrroles; Sterol Regulatory Element Binding Protein 2; Transcription Factors | 2005 |
Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Atorvastatin; Cholesterol, HDL; Chromatography, Liquid; Dogs; Female; Heptanoic Acids; Immunoblotting; Lipase; Liver; Ovariectomy; Phospholipid Transfer Proteins; Phospholipids; Pyrroles; Scavenger Receptors, Class B; Triglycerides | 2006 |
Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages.
Topics: Animals; Atorvastatin; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipase; Lipoprotein Lipase; Liver X Receptors; Macrophages; NF-kappa B; Orphan Nuclear Receptors; Polyisoprenyl Phosphates; Pyrroles; Receptors, Cytoplasmic and Nuclear; Sesquiterpenes; Simvastatin | 2007 |
[Elevation of pancreatic enzymes and facial edema. DRESS syndrome].
Topics: Adrenal Cortex Hormones; Amylases; Atorvastatin; Drug Eruptions; Drug Hypersensitivity Syndrome; Edema; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipase; Middle Aged | 2015 |